Results from the AlzBiom Study

Christoph Laske,Stephan Müller,Matthias H. J. Munk,Iris Honold,Matthias Willmann,Silke Peter,Ulrich Schoppmeier

DOI: https://doi.org/10.3390/ijms25031906

IF: 5.6

2024-02-06

International Journal of Molecular Sciences

Abstract:Alterations in the gut microbiome are associated with the pathogenesis of Alzheimer's disease (AD) and can be used as a diagnostic measure. However, longitudinal data of the gut microbiome and knowledge about its prognostic significance for the development and progression of AD are limited. The aim of the present study was to develop a reliable predictive model based on gut microbiome data for AD development. In this longitudinal study, we investigated the intestinal microbiome in 49 mild cognitive impairment (MCI) patients over a mean (SD) follow-up of 3.7 (0.6) years, using shotgun metagenomics. At the end of the 4-year follow-up (4yFU), 27 MCI patients converted to AD dementia and 22 MCI patients remained stable. The best taxonomic model for the discrimination of AD dementia converters from stable MCI patients included 24 genera, yielding an area under the receiver operating characteristic curve (AUROC) of 0.87 at BL, 0.92 at 1yFU and 0.95 at 4yFU. The best models with functional data were obtained via analyzing 25 GO (Gene Ontology) features with an AUROC of 0.87 at BL, 0.85 at 1yFU and 0.81 at 4yFU and 33 KO [Kyoto Encyclopedia of Genes and Genomes (KEGG) ortholog] features with an AUROC of 0.79 at BL, 0.88 at 1yFU and 0.82 at 4yFU. Using ensemble learning for these three models, including a clinical model with the four parameters of age, gender, body mass index (BMI) and Apolipoprotein E (ApoE) genotype, yielded an AUROC of 0.96 at BL, 0.96 at 1yFU and 0.97 at 4yFU. In conclusion, we identified novel and timely stable gut microbiome algorithms that accurately predict progression to AD dementia in individuals with MCI over a 4yFU period.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve

This paper aims to investigate the predictive value of the gut microbiome in the progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia. Specifically, the researchers hope to develop a reliable predictive model by analyzing taxonomic and functional data of the gut microbiome, combined with clinical parameters, to identify patients who are likely to progress from MCI to AD dementia within the next 4 years.

### Research Methods and Results

1. **Study Design**:
- This study is a longitudinal study that tracked the gut microbiome of 49 MCI patients for up to 3.7 years.
- At the end of the 4-year follow-up, 27 MCI patients had progressed to AD dementia, while 22 MCI patients remained stable.

2. **Main Findings**:
- The best taxonomic model included 24 genera to distinguish patients who progressed from MCI to AD dementia from stable MCI patients, with an AUC of 0.87 at baseline, 0.92 at the 1-year follow-up, and 0.95 at the 4-year follow-up.
- In the functional data models, the best GO model included 25 features, with AUC values of 0.87 (baseline), 0.85 (1-year follow-up), and 0.81 (4-year follow-up); the best KO model included 33 features, with AUC values of 0.79 (baseline), 0.88 (1-year follow-up), and 0.82 (4-year follow-up).
- Combining these three models (taxonomic model, GO model, KO model) with a clinical model that includes age, gender, body mass index (BMI), and apolipoprotein E (ApoE) genotype using an ensemble learning approach, the resulting model had an AUC of 0.96 at baseline, 0.96 at the 1-year follow-up, and 0.97 at the 4-year follow-up.

### Conclusion

The study demonstrates that by analyzing the taxonomic and functional data of the gut microbiome, combined with clinical parameters, it is possible to accurately predict whether MCI patients will progress to AD dementia within the next 4 years. This approach provides a new avenue for early diagnosis and intervention.